ArticleThe Indian journal of medical research2026
Beyond the pyramid: Reconsidering evidence synthesis as distinct from original research.
Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Recalibrating evidence hierarchies in populous low- and middle-income countries: Opportunity cost, epistemic alignment, and the overproduction of systematic reviews.Journal of family medicine and primary care · 2026Review
- The evidence pyramid and its place in informed healthcare decisions: Comments, criticisms, and clarifications.The Indian journal of medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The evidence pyramid, originally intended to guide clinicians and students in understanding levels of clinical evidence. Over time, systematic reviews and meta-analyses were elevated to the apex of this hierarchy, often misconstrued as superior to primary research. Systematic reviews and meta-analyses, while powerful in integrating findings and invaluable for evidence-based practice, remain secondary analyses that depend on the quality of the included studies. Poorly designed or biased trials, coupled with publication bias and redundant syntheses, risk undermining the reliability of aggregated evidence. The current pyramid has inadvertently fostered a culture of desk-based evidence synthesis priority over original, data-generating studies, thereby discouraging innovation. To address these limitations, we propose a dual-framework model that distinguishes original research from evidence syntheses. This model positions randomised controlled trials, large multicentre studies, and qualitative designs within a hierarchy of evidence generation, while treating meta-analysis, realist reviews, and other qualitative syntheses as non-hierarchical but complementary. This effort is to restore balance, encourage methodological pluralism, and promotion of evidence use based on appropriateness and context rather than rigid ranking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.